- Home
- LMAT vs THS Comparison
LMAT vs THS Comparison
Compare LMAT & THS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMAT
- THS
- Stock Information
- Founded
- LMAT 1983
- THS 2021
- Country
- LMAT United States
- THS United States
- Employees
- LMAT N/A
- THS N/A
- Industry
- LMAT Medical/Dental Instruments
- THS Packaged Foods
- Sector
- LMAT Health Care
- THS Consumer Staples
- Exchange
- LMAT Nasdaq
- THS Nasdaq
- Market Cap
- LMAT 2.1B
- THS N/A
- IPO Year
- LMAT 2006
- THS N/A
- Fundamental
- Price
- LMAT $90.62
- THS $35.01
- Analyst Decision
- LMAT Buy
- THS Hold
- Analyst Count
- LMAT 7
- THS 5
- Target Price
- LMAT $92.83
- THS $34.20
- AVG Volume (30 Days)
- LMAT 217.6K
- THS 599.0K
- Earning Date
- LMAT 02-25-2025
- THS 02-14-2025
- Dividend Yield
- LMAT 0.69%
- THS N/A
- EPS Growth
- LMAT 49.21
- THS N/A
- EPS
- LMAT 1.82
- THS N/A
- Revenue
- LMAT $213,029,000.00
- THS $3,359,100,000.00
- Revenue This Year
- LMAT $16.04
- THS N/A
- Revenue Next Year
- LMAT $9.62
- THS $1.26
- P/E Ratio
- LMAT $50.60
- THS N/A
- Revenue Growth
- LMAT 14.81
- THS N/A
- 52 Week Low
- LMAT $52.88
- THS $28.04
- 52 Week High
- LMAT $109.58
- THS $43.84
- Technical
- Relative Strength Index (RSI)
- LMAT 39.25
- THS 55.39
- Support Level
- LMAT $91.28
- THS $34.08
- Resistance Level
- LMAT $94.21
- THS $35.87
- Average True Range (ATR)
- LMAT 2.57
- THS 0.91
- MACD
- LMAT -0.29
- THS 0.27
- Stochastic Oscillator
- LMAT 28.27
- THS 84.96
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.